[시장보고서]비침습적 미용 치료 시장 규모, 점유율 및 동향 분석 보고서 : 치료별, 최종 용도별, 지역별, 부문 예측(2026-2033년)

비침습적 미용 치료 시장 규모, 점유율 및 동향 분석 보고서 : 치료별, 최종 용도별, 지역별, 부문 예측(2026-2033년)

Non-invasive Aesthetic Treatment Market Size, Share & Trends Analysis Report By Procedure (Skin Rejuvenation, Injectable), By End Use (Hospital/Surgery Center, MedSpa, Traditional Spa, HCP owned clinic), By Region, And Segment Forecasts, 2026 - 2033

상품코드 : 1908527

리서치사 : Grand View Research

발행일 : 2025년 12월

페이지 정보 : 영문 110 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,813,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,294,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,256,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

비침습적 미용 치료 시장 개요

세계의 비침습적 미용 치료 시장 규모는 2025년에 359억 9,000만 달러로 평가되었고, 2033년에는 640억 7,000만 달러에 이를 것으로 예측됩니다.

2026-2033년에 걸쳐 CAGR 7.45%로 성장할 전망입니다. 이것은 낮은 위험 미용 치료에 소비자 수요 증가, 기술 발전, 변화하는 라이프스타일 선호도 등에 의해 주도되고 있습니다.

소셜 미디어와 특히 젊은 층을 중심으로 한 미용 인식 증가는 일상적인 미용 관리의 보편화를 촉진하고 있습니다. 또한 고령층의 미묘한 안티에이징 솔루션에 대한 관심과 함께 메디컬 스파, 피부과 클리닉, 소매 건강 시설의 치료 접근성 확대 역시 시장 성장에 기여하고 있습니다.

더불어 증가하는 가처분 소득과 자기 관리 및 웰빙에 대한 집중은 수요를 주도하며, 비침습적 미용 치료을 라이프스타일과 웰빙 루틴의 일환으로 자리매김하게 하고 있습니다.

비침습적 미용 치료 시장 : 치료별 : 주요 포인트
비침습적 미용 치료 시장 : 치료별 변동 분석과 시장 점유율 분석(2025년, 2033년)
주사제
- 보톡스
- 칼슘 하이드록시아파타이트
- 히알루론산
- 폴리머 필러
- 콜라겐
피부 재생
- 화학적 필링
- 레이저 피부 재생
- 포토 리쥬비네이션
기타
- 탈모
- 비수술적 지방 감소
- 경화 요법
- 셀룰라이트 치료

제5장 비침습의 미용 치료 시장 : 최종 용도별, 추정 및 동향 분석

비침습적 미용 치료 시장 : 최종 용도별 : 주요 포인트
비침습적 미용 치료 시장 : 최종 용도별 변동 분석과 시장 점유율 분석(2025년, 2033년)
병원/수술 센터
메디컬 스파
기존 스파
의료 전문가 소유 클리닉

제6장 비침습적 미용 치료 시장 : 지역별, 추정 및 동향 분석

비침습적 미용 치료 시장 : 지역별 변동 분석(2025년, 2033년)
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 태국
- 한국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제7장 비침습적 미용 치료 시장 : 경쟁 구도

기업 분류
기업 점유율 분석(2025년)
전략 매핑
기업 프로파일/목록

HBR

영문 목차

영문목차

Non-invasive Aesthetic Treatment Market Summary

The global non-invasive aesthetic treatment market size was estimated at USD 35.99 billion in 2025 and is projected to reach USD 64.07 billion by 2033, growing at a CAGR of 7.45% from 2026 to 2033. This is driven by rising consumer demand for low-risk cosmetic enhancements, technological advancements, and changing lifestyle preferences.

Social media and increased aesthetic awareness, especially among younger people, are making routine cosmetic maintenance more common. In addition, the aging population's interest in subtle anti-aging solutions, combined with the wider availability of treatments in medical spas, dermatology clinics, and retail health settings, also contributes to market growth.

Moreover, rising disposable incomes and a focus on self-care and wellness are driving demand, making non-invasive aesthetic treatments a regular part of lifestyle and wellbeing routines.

Global Non-invasive Aesthetic Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global non-invasive aesthetic treatment market report based on procedure, end use, and region:

Procedure Outlook (Revenue, USD Million, 2021 - 2033)
Injectables
- Botulinum Toxin
- Calcium Hydroxylapatite
- Hyaluronic Acid
- Polymer Filler
- Collagen
Skin Rejuvenation
- Chemical Peel
- Laser Skin Resurfacing
- Photorejuvenation
- Other Skin Rejuvenation Procedures
Others
- Hair Removal
- Nonsurgical Fat Reduction
- Sclerotherapy
- Cellulite Treatment
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Hospital/Surgery Center
MedSpa
Traditional Spa
HCP owned clinic
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Secondary Sources & Third-Party Perspectives
- 1.4.4. Primary Research
- 1.4.5. Details of Primary Research
1.5. Information Analysis
- 1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Data Validation & Publishing
1.8. List of Abbreviations
1.9. List of Secondary Sources

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segmental Snapshot
2.3. Competitive Insights Snapshot

Chapter 3. Market Variables, Trends, and Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
3.2. Non-invasive Aesthetic Treatment Market - Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Increasing beauty consciousness among consumers
  - 3.2.1.2. Growing geriatric population
  - 3.2.1.3. Increasing adoption of minimally invasive procedures
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Lack of reimbursement coverage
3.3. Industry Analysis Tools: Non-invasive Aesthetic Treatment Market
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PEST Analysis
3.4. COVID-19 Impact Analysis

Chapter 4. Non-invasive Aesthetic Treatment Market: Procedure Estimates & Trend Analysis

4.1. Non-invasive Aesthetic Treatment Market, By Procedure: Key Takeaways
4.2. Non-invasive Aesthetic Treatment Market: Procedure Movement & Market Share Analysis, 2025 & 2033
4.3. Injectables
- 4.3.1. Global Injectables Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.3.2. Botulinum Toxin
  - 4.3.2.1. Global Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.3.3. Calcium Hydroxylapatite
  - 4.3.3.1. Global Calcium Hydroxylapatite Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.3.4. Hyaluronic Acid
  - 4.3.4.1. Global Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.3.5. Polymer Filler
  - 4.3.5.1. Global Polymer Filler Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.3.6. Collagen
  - 4.3.6.1. Global Collagen Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
4.4. Skin Rejuvenation
- 4.4.1. Global Skin Rejuvenation Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.4.2. Chemical Peel
  - 4.4.2.1. Global Chemical PeelMarket Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.4.3. Laser Skin Resurfacing
  - 4.4.3.1. Global Laser Skin Resurfacing Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.4.4. Photorejuvenation
  - 4.4.4.1. Global Photorejuvenation Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
4.5. Others
- 4.5.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.5.2. Hair Removal
  - 4.5.2.1. Global Hair Removal Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.5.3. Nonsurgical Fat Reduction
  - 4.5.3.1. Global Nonsurgical Fat Reduction Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.5.4. Sclerotherapy
  - 4.5.4.1. Global Sclerotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.5.5. Cellulite Treatment
  - 4.5.5.1. Global Cellulite Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Non-invasive Aesthetic Treatment Market: End Use Estimates & Trend Analysis

5.1. Non-invasive Aesthetic Treatment Market, By End Use: Key Takeaways
5.2. Non-invasive Aesthetic Treatment Market: End Use Movement & Market Share Analysis, 2025 & 2033
5.3. Hospital/Surgery Center
- 5.3.1. Global Hospital/Surgery Center Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.4. Medspa
- 5.4.1. Global Medspa Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.5. Traditional Spa
- 5.5.1. Global Traditional Spa Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.6. HCP owned clinic
- 5.6.1. Global HCP owned clinic Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Non-invasive Aesthetic Treatment Market: Regional Estimates & Trend Analysis

6.1. Non-invasive Aesthetic Treatment Market: Regional Movement Analysis, 2025 & 2033
6.2. North America
- 6.2.1. North America Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.2.2. U.S.
  - 6.2.2.1. Key Country Dynamics
  - 6.2.2.2. Competitive Scenario
  - 6.2.2.3. U.S. Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.2.3. Canada
  - 6.2.3.1. Key Country Dynamics
  - 6.2.3.2. Competitive Scenario
  - 6.2.3.3. Canada Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.2.4. Mexico
  - 6.2.4.1. Key Country Dynamics
  - 6.2.4.2. Competitive Scenario
  - 6.2.4.3. Mexico Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.3. Europe
- 6.3.1. Europe Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.3.2. UK
  - 6.3.2.1. Key Country Dynamics
  - 6.3.2.2. Competitive Scenario
  - 6.3.2.3. UK Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.3.3. Germany
  - 6.3.3.1. Key Country Dynamics
  - 6.3.3.2. Competitive Scenario
  - 6.3.3.3. Germany Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.3.4. France
  - 6.3.4.1. Key Country Dynamics
  - 6.3.4.2. Competitive Scenario
  - 6.3.4.3. France Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.3.5. Italy
  - 6.3.5.1. Key Country Dynamics
  - 6.3.5.2. Competitive Scenario
  - 6.3.5.3. Italy Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.3.6. Spain
  - 6.3.6.1. Key Country Dynamics
  - 6.3.6.2. Competitive Scenario
  - 6.3.6.3. Spain Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.3.7. Denmark
  - 6.3.7.1. Key Country Dynamics
  - 6.3.7.2. Competitive Scenario
  - 6.3.7.3. Denmark Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.3.8. Sweden
  - 6.3.8.1. Key Country Dynamics
  - 6.3.8.2. Competitive Scenario
  - 6.3.8.3. Sweden Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.3.9. Norway
  - 6.3.9.1. Key Country Dynamics
  - 6.3.9.2. Competitive Scenario
  - 6.3.9.3. Norway Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.4. Asia Pacific
- 6.4.1. Asia Pacific Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.4.2. Japan
  - 6.4.2.1. Key Country Dynamics
  - 6.4.2.2. Competitive Scenario
  - 6.4.2.3. Japan Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.4.3. China
  - 6.4.3.1. Key Country Dynamics
  - 6.4.3.2. Competitive Scenario
  - 6.4.3.3. China Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.4.4. India
  - 6.4.4.1. Key Country Dynamics
  - 6.4.4.2. Competitive Scenario
  - 6.4.4.3. India Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.4.5. Australia
  - 6.4.5.1. Key Country Dynamics
  - 6.4.5.2. Competitive Scenario
  - 6.4.5.3. Australia Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.4.6. Thailand
  - 6.4.6.1. Key Country Dynamics
  - 6.4.6.2. Competitive Scenario
  - 6.4.6.3. Thailand Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.4.7. South Korea
  - 6.4.7.1. Key Country Dynamics
  - 6.4.7.2. Competitive Scenario
  - 6.4.7.3. South Korea Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.5. Latin America
- 6.5.1. Latin America Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.5.2. Brazil
  - 6.5.2.1. Key Country Dynamics
  - 6.5.2.2. Competitive Scenario
  - 6.5.2.3. Brazil Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.5.3. Argentina
  - 6.5.3.1. Key Country Dynamics
  - 6.5.3.2. Competitive Scenario
  - 6.5.3.3. Argentina Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.6. Middle East & Africa
- 6.6.1. Middle East & Africa Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.6.2. South Africa
  - 6.6.2.1. Key Country Dynamics
  - 6.6.2.2. Competitive Scenario
  - 6.6.2.3. South Africa Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.6.3. Saudi Arabia
  - 6.6.3.1. Key Country Dynamics
  - 6.6.3.2. Competitive Scenario
  - 6.6.3.3. Saudi Arabia Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.6.4. UAE
  - 6.6.4.1. Key Country Dynamics
  - 6.6.4.2. Competitive Scenario
  - 6.6.4.3. UAE Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.6.5. Kuwait
  - 6.6.5.1. Key Country Dynamics
  - 6.6.5.2. Competitive Scenario
  - 6.6.5.3. Kuwait Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Non-invasive Aesthetic Treatment Market: Competitive Landscape

7.1. Company Categorization
7.2. Company Market Share Analysis, 2025
7.3. Strategy Mapping
7.4. Company Profiles/Listing
- 7.4.1. Hologic, Inc.
  - 7.4.1.1. Overview
  - 7.4.1.2. Financial Performance
  - 7.4.1.3. Service Benchmarking
  - 7.4.1.4. Strategic Initiatives
- 7.4.2. Allergan, Inc.
  - 7.4.2.1. Overview
  - 7.4.2.2. Financial Performance
  - 7.4.2.3. Service Benchmarking
  - 7.4.2.4. Strategic Initiatives
- 7.4.3. Galderma S.A.
  - 7.4.3.1. Overview
  - 7.4.3.2. Financial Performance
  - 7.4.3.3. Service Benchmarking
  - 7.4.3.4. Strategic Initiatives
- 7.4.4. Alma Lasers
  - 7.4.4.1. Overview
  - 7.4.4.2. Financial Performance
  - 7.4.4.3. Service Benchmarking
  - 7.4.4.4. Strategic Initiatives
- 7.4.5. Syneron Candela
  - 7.4.5.1. Overview
  - 7.4.5.2. Financial Performance
  - 7.4.5.3. Service Benchmarking
  - 7.4.5.4. Strategic Initiatives
- 7.4.6. Johnson & Johnson
  - 7.4.6.1. Overview
  - 7.4.6.2. Financial Performance
  - 7.4.6.3. Service Benchmarking
  - 7.4.6.4. Strategic Initiatives
- 7.4.7. Merz Pharma
  - 7.4.7.1. Overview
  - 7.4.7.2. Financial Performance
  - 7.4.7.3. Service Benchmarking
  - 7.4.7.4. Strategic Initiatives
- 7.4.8. Lumenis
  - 7.4.8.1. Overview
  - 7.4.8.2. Financial Performance
  - 7.4.8.3. Service Benchmarking
  - 7.4.8.4. Strategic Initiatives
- 7.4.9. Solta Medical
  - 7.4.9.1. Overview
  - 7.4.9.2. Financial Performance
  - 7.4.9.3. Service Benchmarking
  - 7.4.9.4. Strategic Initiatives
- 7.4.10. Cutera Inc.
  - 7.4.10.1. Overview
  - 7.4.10.2. Financial Performance
  - 7.4.10.3. Service Benchmarking
  - 7.4.10.4. Strategic Initiatives
- 7.4.11. Revance Therapeutics Inc.
  - 7.4.11.1. Overview
  - 7.4.11.2. Financial Performance
  - 7.4.11.3. Service Benchmarking
  - 7.4.11.4. Strategic Initiatives